The HCC (~90% of all PLC) and iCC have been described as independent tumours that originate from distinct cell populations, as well as exhibit distinct histological, molecular and clinical features but share some of the risk factors and oncogenic pathways [78,92,93,94]. Here, HSPG2 is linked to hepatocellular carcinoma.